Aster DM Healthcare Ltd
BSE:540975
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kempower Oyj
OMXH:KEMPOWR
|
FI |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (32), the stock would be worth ₹365.54 (47% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 59.8 | ₹684.35 |
0%
|
| 3-Year Average | 32 | ₹365.54 |
-47%
|
| 5-Year Average | 24 | ₹274.35 |
-60%
|
| Industry Average | 42.5 | ₹486.44 |
-29%
|
| Country Average | 23.3 | ₹266.09 |
-61%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
₹338.3B
|
/ |
Jan 2026
₹6B
|
= |
|
|
₹338.3B
|
/ |
Mar 2026
₹6.6B
|
= |
|
|
₹338.3B
|
/ |
Mar 2027
₹11.2B
|
= |
|
|
₹338.3B
|
/ |
Mar 2028
₹14.6B
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| IN |
|
Aster DM Healthcare Ltd
BSE:540975
|
353.8B INR | 59.8 | 108.2 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
108.2B USD | 12.2 | 15.9 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 40 | 40.8 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
24B ZAR | 9.4 | 14.3 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
77.8B MYR | 22.8 | 37.1 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
18B ZAR | -53.5 | 4.7 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
85.3B BRL | 9.2 | 18.2 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
16.4B USD | 7 | 11.7 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
91.9B CNY | 20.8 | 29.3 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 43.3 | 61.9 | |
| US |
|
Universal Health Services Inc
NYSE:UHS
|
11.1B USD | 7.5 | 7.4 |
Market Distribution
| Min | 0.4 |
| 30th Percentile | 15.7 |
| Median | 23.3 |
| 70th Percentile | 34.7 |
| Max | 48 145.1 |
Other Multiples
Aster DM Healthcare Ltd
Glance View
Aster DM Healthcare Ltd. emerged from humble beginnings in 1987, founded by Dr. Azad Moopen, who envisioned a network that would deliver quality healthcare across varying geographies. What started with a single clinic in Dubai rapidly expanded into a sprawling healthcare conglomerate operating across multiple nations. Aster DM Healthcare's model rests on a comprehensive approach that includes hospitals, clinics, diagnostic centers, and pharmacies, providing an integrated continuum of care. This diversity is the essence of its operational strategy; ensuring patient needs are addressed at every touchpoint, be it an initial consultation at a clinic, diagnostics, specialized treatment, or the procurement of medications. The company's vast geographical footprint spans the Middle East, India, and beyond, tapping into regions where demand for accessible and quality healthcare continues to rise. This expansive portfolio allows Aster DM Healthcare to generate revenue through a variety of streams, capitalizing on its ability to cater to both the premium segment and more cost-sensitive patients. Hospitals and clinics serve as the primary engine for revenue, offering a range of services from routine health check-ups to complex surgeries. Diagnostics centers add an additional layer of profitability, catering to the growing demand for precise medical testing. Meanwhile, the pharmacy network expands the firm's reach beyond healthcare facilities, serving as a convenient healthcare touchpoint within communities. This multi-pronged approach not only maximizes revenue but also enhances overall operational resilience, ensuring that the company can weather market fluctuations and invest in technological advancements to improve patient care further.